Cargando…
Real World Treatment Practices for Mantle Cell Lymphoma in Japan: An Observational Database Research Study (CLIMBER-DBR)
Mantle cell lymphoma (MCL) accounts for approximately 3% of all cases of malignant lymphoma in Japan. The CLIMBER-DBR (Treatment practices and patient burden in chronic lymphocytic leukemia and mantle cell lymphoma patients in the real world: An observational database research in Japan) study examin...
Autores principales: | Izutsu, Koji, Suzumiya, Junji, Takizawa, Jun, Fukase, Kenjiro, Nakamura, Maki, Jinushi, Masahisa, Nagai, Hirokazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JSLRT
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519241/ https://www.ncbi.nlm.nih.gov/pubmed/34092722 http://dx.doi.org/10.3960/jslrt.20056 |
Ejemplares similares
-
Real World Treatment Practices for Chronic Lymphocytic Leukemia in Japan: An
Observational Database Research Study (CLIMBER-DBR)
por: Takizawa, Jun, et al.
Publicado: (2021) -
Dose-escalation part of Phase I study of single-agent mosunetuzumab in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma
por: Munakata, Wataru, et al.
Publicado: (2023) -
A phase II Japanese trial of fludarabine, cyclophosphamide and rituximab for previously untreated chronic lymphocytic leukemia
por: Izutsu, Koji, et al.
Publicado: (2020) -
Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group
por: Yoon, Dok Hyun, et al.
Publicado: (2020) -
Safety and antitumor activity of acalabrutinib for relapsed/refractory B‐cell malignancies: A Japanese phase I study
por: Izutsu, Koji, et al.
Publicado: (2021)